z-logo
open-access-imgOpen Access
Iris in an HIV seropositive leprosy patient
Author(s) -
Vineet Kaur,
Gurmohan Singh
Publication year - 2006
Publication title -
leprosy review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 43
eISSN - 2162-8807
pISSN - 0305-7518
DOI - 10.47276/lr.77.4.386
Subject(s) - medicine , leprosy , iris (biosensor) , human immunodeficiency virus (hiv) , immune reconstitution inflammatory syndrome , dermatology , virology , immunology , antiretroviral therapy , viral load , computer science , biometrics , computer security
We read with interest the case report on the above subject. The authors have described a case of BL type of leprosy with type II reaction, who also had AIDS at the time of first presentation. The patient had the disease for over 2 years and ENL for 6 months. The course of the disease after the initiation of anti-leprosy treatment (ALT) was as expected in most cases. The ALT comprised rifampicin 600mg monthly, ofloxacin 400mg daily, minocycline 100mg daily and clofazimine 100mg thrice daily for 4 weeks, after which minocycline and ofloxacin were withdrawn. After 3 months of ALT, HAART was instituted along with the ALT. On giving ALT, the immunological status improves and is known to produce type I reaction in many cases, which is what happened with this patient. In this case, all the described symptoms appeared 1 month after HAART, which could be coincidental. Those of us who see and follow up a huge number of leprosy cases know that this is not an uncommon phenomenon in uncomplicated BL type of leprosy patients. Four criteria have been given by the authors to diagnose a case as IRIS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom